Quality by Design Framework Applied to GMMA Purification
- Carlo Giannelli 1, Francesca Necchi 2, Elena Palmieri 2, Davide Oldrini 2, Beatrice Ricchetti 2, Maria M Papathanasiou 3, Zoltan Kis 3,4, Cleo Kontoravdi 3, Cristiana Campa 5, Francesca Micoli 2
- 1GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100, Siena, Italy. carlo.x.giannelli@gsk.com.
- 2GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100, Siena, Italy.
- 3The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
- 4Department of Chemical and Biological Engineering, The University of Sheffield, Mappin Street, Sheffield, S1 3JD, UK.
- 5GSK, Via Fiorentina 1, 53100, Siena, Italy.
- 0GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100, Siena, Italy. carlo.x.giannelli@gsk.com.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Generalized Modules for Membrane Antigens (GMMA) offer a simple manufacturing approach for vaccines against bacterial pathogens. Implementing a quality by design framework ensures consistent production for global health initiatives.
Area Of Science
- Vaccinology
- Biopharmaceutical Manufacturing
- Quality by Design
Background
- Generalized Modules for Membrane Antigens (GMMA) are emerging as a promising vaccine platform.
- Their manufacturing simplicity makes them particularly suitable for low- and middle-income countries.
- Robust manufacturing is crucial for vaccine efficacy and accessibility.
Purpose Of The Study
- To outline a Quality by Design (QbD) framework for GMMA manufacturing.
- To identify critical quality attributes (CQAs) and process parameters for GMMA production.
- To support the development and control of GMMA-based vaccine manufacturing processes.
Main Methods
- Application of QbD principles to GMMA production.
- Assessment of critical quality attributes (CQAs).
- Analysis of product-process interactions and in-process analytical methods.
Main Results
- A systematic methodology for QbD implementation in GMMA manufacturing is proposed.
- The approach facilitates the control of manufacturing processes for consistent batch characteristics.
- Initial steps of GMMA manufacturing process were analyzed using the suggested methodology.
Conclusions
- QbD implementation is essential for robust GMMA manufacturing.
- This framework supports technical transfer, regulatory approval, and commercialization of GMMA vaccines.
- The presented methodology aids in ensuring the quality and consistency of GMMA-based vaccines.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

